Date of Award
Spring 5-5-2018
Document Type
DNP Project
Project Team Faculty Member
Dr. Linda Omondi
Project Team Faculty Member
Dr. Kathy Ketchum
Project Team Faculty Member
Dr. Kim White
Keywords
Narcan, naloxone, Opiate Education and Naloxone Distribution, overdose
Abstract
Abstract
Trends indicate that misuse of opiates has increased nationally, frequently resulting in death. Substance use treatment clinics are now distributing naloxone (Narcan) to clients and laypeople as an antidote for opiate-related overdose. Offering Opiate Education and Naloxone Distribution (OEND) programs at treatment facilities increase the naloxone education opportunities available to those most closely affected by overdose.
Methods: The evaluation of naloxone distribution at a Midwestern substance use disorder clinic involved a retrospective analysis via chart audit of data regarding the delivery and administration of naloxone. The project focused on 48 individuals in the initial treatment phase for opiate use disorder with Methadone who received naloxone from April to January of 2017.
Results: A total of 48 (N = 48) clients received naloxone. Of these 48 clients, 15% (n = 7) required replacement naloxone. Of those 7 clients, 71.4% (n = 5) used naloxone for a witnessed opiate-related overdose.
Conclusion: When properly educated on opiates and naloxone, clients will use naloxone for a witnessed opiate-related overdose. OEND programs are needed in communities with increased incidence of opiate-related deaths. An evidence-based guideline for an OEND program would be the next step to provide the best education and support for clients. Further data regarding client perspectives of naloxone use would also be beneficial.
Keywords: Narcan, naloxone, Opiate Education and Naloxone Distribution, overdose
Recommended Citation
Tyler, Ashley M., "A Retrospective Analysis of an Opiate Education and Naloxone Distribution Program" (2018). Doctor of Nursing Practice Projects. 24.
https://spark.siue.edu/dnpprojects/24
Download Full Text Above
Problem Statement_ashlero.docx (15 kB)
Clinical Relevance_ashlero.docx (16 kB)
Literature Review_ashlero.docx (31 kB)
Conceptual Framework_ashlero.docx (16 kB)
Methodology_ashlero.docx (19 kB)
Evaluation_ashlero.docx (17 kB)
References_ashlero.docx (17 kB)